Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Clinical trial NCT05413421 · RECRUITING

Trial details

NCT number: NCT05413421
Sponsor: ORIC Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2022-06-01
Primary completion: 2027-06-01
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.